Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
British American Tobacco ( (GB:BATS) ) has issued an update.
British American Tobacco has executed a share buyback, purchasing 138,569 ordinary shares at an average price of 3,030.7749 pence per share. This move, part of a broader buyback program, aims to cancel the acquired shares, thereby reducing the total number of shares in circulation and potentially increasing shareholder value. The transaction reflects the company’s strategic focus on enhancing shareholder returns and optimizing its capital structure.
The most recent analyst rating on (GB:BATS) stock is a Hold with a £29.00 price target. To see the full list of analyst forecasts on British American Tobacco stock, see the GB:BATS Stock Forecast page.
Spark’s Take on GB:BATS Stock
According to Spark, TipRanks’ AI Analyst, GB:BATS is a Neutral.
British American Tobacco’s overall stock score of 63 reflects strong cash flow and dividend yield, appealing to income investors. However, earnings volatility and market challenges weigh on the assessment. The company’s financial performance is solid, yet technical trends show stability without strong momentum. Valuation remains moderately attractive, but the high P/E ratio and external challenges limit immediate upside potential.
To see Spark’s full report on GB:BATS stock, click here.
More about British American Tobacco
British American Tobacco p.l.c. operates in the tobacco industry, focusing on the production and sale of cigarettes and other nicotine products. The company is a major player in the global market, known for its diverse portfolio of brands and commitment to reducing the health impact of its products.
Average Trading Volume: 5,711,486
Technical Sentiment Signal: Strong Buy
Current Market Cap: £66.44B
See more insights into BATS stock on TipRanks’ Stock Analysis page.